Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep:143:104976.
doi: 10.1016/j.nbd.2020.104976. Epub 2020 Jun 18.

Genetic architecture of Alzheimer's disease

Sarah M Neuner  1 , Julia Tcw  1 , Alison M Goate  2
Affiliations
Review

Genetic architecture of Alzheimer's disease

Sarah M Neuner et al. Neurobiol Dis. 2020 Sep.

Abstract

Advances in genetic and genomic technologies over the last thirty years have greatly enhanced our knowledge concerning the genetic architecture of Alzheimer's disease (AD). Several genes including APP, PSEN1, PSEN2, and APOE have been shown to exhibit large effects on disease susceptibility, with the remaining risk loci having much smaller effects on AD risk. Notably, common genetic variants impacting AD are not randomly distributed across the genome. Instead, these variants are enriched within regulatory elements active in human myeloid cells, and to a lesser extent liver cells, implicating these cell and tissue types as critical to disease etiology. Integrative approaches are emerging as highly effective for identifying the specific target genes through which AD risk variants act and will likely yield important insights related to potential therapeutic targets in the coming years. In the future, additional consideration of sex- and ethnicity-specific contributions to risk as well as the contribution of complex gene-gene and gene-environment interactions will likely be necessary to further improve our understanding of AD genetic architecture.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Genetic loci associated with Alzheimer’s disease (AD).
A literature search was used to identify studies reporting genomic loci associated with either risk for AD or various endophenotypes including cerebrospinal fluid measurements of amyloid and/or tau, amyloid deposition as measured by positon emission tomography (PET) or postmortem studies, and brain glucose metabolism as measured by fluorodeoxyglucose (FDG)-PET. Genes with sufficient functional evidence to suggest they are the causal gene in their respective loci are annotated on the figure. Unlabeled loci indicate the causal gene in the region is still unknown. Source information for this figure can be found in Supplementary Table 1. Phenogram was constructed at http://visualization.ritchielab.org/phenograms and modified in Adobe Illustrator for clarity.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alzheimer’s Association. (2019). 2019 Alzheimer’s disease facts and figures. Alzheimer’s & dementia: the journal of the Alzheimer’s Association, 15(3), 321–387.
    1. Cacace R, Sleegers K, & Van Broeckhoven C (2016). Molecular genetics of early-onset Alzheimer’s disease revisited. Alzheimer’s & dementia: the journal of the Alzheimer’s Association, 12(6), 733–748. - PubMed
    1. Karantzoulis S, & Galvin JE (2011). Distinguishing Alzheimer’s disease from other major forms of dementia. Expert review of neurotherapeutics, 11(11), 1579–1591. - PMC - PubMed
    1. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, … Phelps CH (2011). The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & dementia: the journal of the Alzheimer’s Association, 7(3), 263–269. - PMC - PubMed
    1. Selkoe DJ (1991). The molecular pathology of Alzheimer’s disease. Neuron, 6(4), 487–498. - PubMed

Publication types

MeSH terms